when

Latest
Archive

by source

All Sources
Sources Page

department

Clinical
Regulatory
Medical Affairs
Commercial
R&D / Discovery
Biostatistics / Data
Manufacturing / CMC
Market Access

therapeutic area

Oncology
Immunology
Neuroscience
Cardiovascular
Metabolic
Rare Disease
Infectious Disease

location & type

Remote Only
US Only
California
Massachusetts
Internships
Phase 3 Roles
All Jobs →

by stage

Marketed
Phase 3
Phase 2
Phase 1
Preclinical

browse

Most catalysts
Recently active
All drugs →
Companies
Patent cliff

what

Trial readouts
PDUFA dates
Approvals
Earnings

when

Upcoming
Month grid
Recently passed

Sign In Subscribe

pharmadog

fetch the data · sniff the signal

Discover

Jobs
News
Drugs
Calendar
Companies

Hubs

Topics
Patent cliff
Publications
Readouts

Tools

Compare
Search
Bookmarks

Trust

About
Sources
Contact

Legal

Privacy
Terms
Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

home
jobs
news
search

Small Molecules · news · pharmadog

← back to Small Molecules

News mentioning Small Molecules

38 stories

2dGate CEO sees expanded $870M pact with Lilly as ‘vote of confidence’ in biotech’s platformfiercebiotech

3dFoghorn cuts 40% of workforcebiospace

3dDavid Sinclair's latest salvo aims to stall aging with a pillendpoints

5dWebinar: From Facility to Delivery: Solving the Complex Science of ADC Linker-Payload Synthesisbiospace

6d‘We’re so close to the tech companies’: Genentech CEO talks Fierce through vision for the futurefiercebiotech

11dRoche inks up to $2B deal with Atavistik for new cardiometabolic drugsbiospace

11dRoche pens backloaded $2B deal with Atavistik to discover allosteric CVRM drugsfiercebiotech

18dLilly-backed Orbis does up to $1.4B macrocycle deal with Novoendpoints

19dNovo explores macrocycles’ potential in $1.4B cardiometabolic pact with Danish biotechfiercebiotech

19dNovartis pays Sironax $125M to acquire platform for crossing the blood-brain barrierfiercebiotech

21dCyclic peptides open new drug frontiers, if manufacturing can keep upbiospace

24dKaryopharm pushes off debt payment; Amgen eyes broader Imdelltra usebiopharma dive

24dTakeda’s long-term R&D head announces exit after major pipeline reorganizationbiospace

26dSchrödinger births new immunology and inflammation biotech, Tectora Therapeuticsfiercebiotech

27dBrainChild Bio gets $116M for pivotal trial of pediatric brain tumor CAR-Tendpoints

27dAI will only revolutionize drug discovery and development if we play to its strengthsbiospace

27d4 CDMOs to consider when outsourcing manufacturingbiospace

Sep 4, 2610 life sciences startups selected for accelerator programbiospace

Sep 2, 26Beyond GLP‑1s: The race for next‑gen obesity drugs starts in the preclinical modelsbiospace

Aug 26, 26Research into protein interactions sheds new light on causes of autismfiercebiotech

Aug 25, 26After some ‘tough years,’ Frontier’s CEO is ramping up ambitions for precision med platformfiercebiotech

Aug 20, 26STAT+: One of the most consequential years for cancer treatment, everstat

Aug 18, 26BioMarin bulks up bone unit with $275M Alesta buyout to challenge AstraZenecafiercebiotech

Aug 14, 26Capricor soars on potential FDA review extension, filing amendmentsbiospace

Aug 14, 26‘We’re not afraid of competition’: BioCryst CEO sets out strategy after scrapping internal discoveryfiercebiotech

Aug 13, 26Chutes & Ladders—Former Legend CEO lands at K2fiercebiotech

Aug 12, 26Pfizer’s former chemistry whiz debuts Khartis Therapeutics with $95M for thyroid eye disease pillfiercebiotech

Aug 12, 26With tech backing, AI biotechs force biopharma into ‘fail-fast’ drug developmentbiospace

Aug 11, 26Building Resilience for the Future of Biopharma Innovationfiercebiotech

Aug 10, 26BMS picks Texas for new $2.3B manufacturing campusbiospace

← prevpage 1 of 2next →